Perioperative anesthetic management in pediatric with pheochromocytoma tumor resection by Thius, Adi Dharma et al.
           CASE REPORT






Pheochromocytomas (PCC) is rarely seen among 
the pediatric population, and its intraoperative 
management is as similar as an adult case. The 
majority of patients have refractory hypertension 
as the most common clinical presentation; hence 
the comprehensive optimization prior surgery 
should be mandatory.1 The careful assessment of 
several preoperative risk factors and prevention of 
untoward perioperative complications - induced 
hemodynamic turmoil to lead to the main favorable 
physiology and pharmacologic aspects in optimiz-
ing perioperative outcome. 
CASE REPORT
A 13-year-old, 34 kg male presented with severe 
headache and history of hypertension recognized 
since six months prior. His headache has been 
getting worse and further followed by blurry vision 
complaints. The previous medical history revealed 
hemorrhagic stroke without hemiparesis sequelae. 
He was treated in the intermediate ward to opti-
mize his blood pressure with Captopril 50mg every 
8 hours, extended release of nifedipine 30 mg every 
24 hours and titrated nicardipine infusion. His blood 
pressure range was in 170-200/100-120 mmHg. 
Complete blood count showed normal leuco-
cyte count (10.52 x 103/uL), slightly decreased 
hemoglobin (10.71 g/dL), normal hematocrit 
(32.33%), and normal platelet (465.3 x 103/uL). 
His coagulation profile returned normal, as well 
as his chemical blood panels and electrolytes. The 
imaging result of plain abdominal x-ray was unre-
markable. Meanwhile, further test by abdominal 
CT angiography showed bilateral benign masses on 
the suprarenal site suspected PCC or renal without 
the significant appearance of stenosis, aneurysm, 
thrombus, or arteriovenous malformation  (AVM) 
in descendent aortic, abdominal aortic, along with 
both side left and right of renal and iliac commu-
nicant arteries. Preoperative echocardiography has 
only found mild tricuspid regurgitation (TR) with 
normal left ventricle (LV) systolic function, with 
acceptable ejection fraction (EF) of 80.73%. 
He was scheduled for tumor removal. Upon 
arrival at the preparation room, his blood pressure 
(BP) was 150/100 mmHg (mean arterial pressure/
MAP was 116 mmHg), tachycardia with heart rate 
(HR) 130 beat per minute (bpm), and otherwise 
were unremarkable. He was given premedication 
intravenously (IV) with midazolam 2 mg IV and 
fentanyl 15 mcg. The continuous nicardipine infu-
sion was initially set to 3 mcg/kg/hour; then we 
gradually titrated it to reach a 20% reduction of 
MAP (to about 93 mmHg). 
A standard ASA monitoring along with arterial 
line monitoring and central venous catheter (CVC) 
was attached. He received pre-oxygenation and 
dexmedetomidine loading dose 1 mcg/kg within 
10 minutes, continued with 0.2-0.7 mcg/kg/min 
as maintenance. Induction of anesthesia was given 
with titrated propofol 70 mg, fentanyl 70 mcg, and 
rocuronium 40 mg. We used air/oxygen mixture 
with sevoflurane to maintain anesthesia. The 
target of systolic blood pressure (SBP) was within 
120-130 mmHg and HR 80-100 bpm which were 
achieved by adjustment and titration doses of 
dexmedetomidine, nitroglycerin, and nicardipine. 
The urine production was targeted to 0.5-1 mL/kg/
hour and body temperature 36.5-37.5°C.
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Pheochromocytomas (PCC) is rare neuroendocrine tumors which 
present as the malignant and familial features. These catecholamine-
secreting tumors have classic triad symptoms of headache, sweating, 
and palpitation primarily due to the release of catecholamines and their 
metabolites in the body with hypertensive crisis become its predominant 
clinical symptoms. The excessive release of catecholamines may produce 
a life-threatening hemodynamic surge during the intraoperative period. 
Therefore preoperative preparation and intraoperative monitoring 
become an essential point. Nevertheless, postoperative care is also a 
critical issue to curtail its morbidity and mortality rates further. 
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During surgery, the removal of the left suprare-
nal tumor was uneventful. Meanwhile, there was 
massive bleeding after right suprarenal tumor resec-
tion leads to hypovolemic shock. It happened after 
releasing tumor out of inferior vena cava. The blood 
pressure immediately dropped to 60/30  mmHg. 
Hence the fluid resuscitation with massive blood 
transfusion protocols of the packed red cell (PRC) 
and fresh frozen plasma (FFP) was promptly 
administered. The vasodilators drugs were stopped 
and switched to inotropic and vasoconstrictor with 
adrenaline, norepinephrine, and dobutamine along 
with continued ketamine infusion as maintenance.
Furthermore, vasopressin and hydrocortisone 
were given to overcome the post-resection vasople-
gic effect. At the end of the surgery, his hemody-
namic state was kept stable with BP range within 
110-120/70-90 mmHg, HR 90-100 bpm, SpO2 
99% on controlled ventilation, and urine output 
0.8 mL/kgBW/hour. We transferred him to the 
Pediatric Intensive Care Unit (PICU) for intensive 
monitoring and tapered off the doses of dobuta-
mine, vasopressin, and norepinephrine. 
He was brought to fully awake status and extu-
bated on the third day after the surgery, and the 
hemodynamic state was gradually returning to 
initial preoperative level (140-170/90-110 mmHg). 
Hence blood pressure medication was continued 
by nicardipine infusion only. Proper blood glucose 
monitoring was also addressed with targeted level 
to 110-180 mg/dL. He was admitted in PICU for 
seven days and discharged after 11 days of total 
admission with last recorded BP was 120/80 mmHg 
with amlodipine 10 mg every 24 hours as his take-
home medicine. Anatomical pathology result was 
per PCC morphological features.
DISCUSSION
PCC is a rare catecholamine-secreting tumor of 
suprarenal medulla with its annual incidence rate is 
around 0.2-0.8 per 100.000 population. The genetic 
mutation is known as a predominant cause which 
is an autosomal dominant inherited. The classical 
eponym of “ten-percentage tumor” from PCC 
itself is referred to some features namely 10% are 
malignant, 10% are the extra-adrenal site, 10% are 
familial, 10% are found bilaterally, and 10% are 
in normotensive patients. However, these initial 
attributes may not be longer used due to several 
recent contradictory studies which have otherwise 
found that higher tumor proportions with malig-
nant trait as high as 29%, the extra-adrenal site 
reaches to 24%, and familial origin extends to 32% 
proportion.2 
PCC has classic triad symptoms of headache, 
sweating, and palpitation primarily due to the 
release of catecholamines and their metabolites in 
the body. Furthermore, the other constitutional 
symptoms include hypertension, fatigue, sweat-
ing, nausea, weight loss, constipation, feverish and 
pallor-appearance. Long-standing exposure to 
the catecholamines accumulation lead to dilated 
cardiomyopathy, ventricular failure, myocardial 
infarction, arrhythmia, stroke, and other cardiovas-
cular ischemic diseases. 
The clinical symptoms of headache and hyper-
tension are mostly associated with norepineph-
rine-secreting tumors, meanwhile other symptoms 
for instance palpitation, sweating, anxious, and 
panic attack are suspected due to epinephrine or 
dopamine secreting tumors. Sympathetic nervous 
system stimulation releases an excessive amount 
of norepinephrine on the synaptic cleft which will 
manifest as hypertensive crisis.3 
The aims of preoperative management include 
control of arterial pressure, heart rate and arrhyth-
mia, restoring of intravascular volume depletion, 
myocardial function optimization, as well as 
improve the blood glucose and electrolyte distur-
bance. PCC tumor resection belongs to one of 
the crucial challenges for an anesthesiologist with 
regards to careful monitoring of hemodynamic 
stability due to several anaesthesia-induced cate-
cholamine releases procedures, for example during 
direct laryngoscopy and intubation procedures, 
peritoneum insufflation, surgery stimulations, and 
tumor removal, followed by some unpredictable 
possible complication post ligations. The meticu-
lous perioperative anesthesia planning and not to 
mention, the thoughtful communication with the 
surgeon will be needed. 
The first key point is how to overcome the patient’s 
anxiety before induction to avoid any upsurges 
of catecholamine release. Ideally, a long-acting 
benzodiazepine class, for instance, lorazepam or 
diazepam should be administered one-night prior 
surgery along with midazolam intravenously just 
before the patient is transferred to the operating 
theatre. It is useful for patient relief and put them 
on less susceptible state towards induction-induced 
hypertensive crisis. 
It is an absolute indication to administer inva-
sive arterial pressure monitoring in all of the 
patients with PCC prior anesthesia induction as 
the continuous beat-to-beat monitoring will bring 
hemodynamic state through closely observed, espe-
cially during direct laryngoscopy and endotracheal 
intubation. A large bore of peripheral IV should 
also be placed routinely.4 Histamine receptor-2 
antagonist (H2 blockers) can be given as an option, 
however certain antiemetic, for instance, metoclo-
pramide should be avoided as it triggers a sudden 
hypertensive crisis. Furthermore, short-acting 
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Alpha 1 antagonists can be given in the morning 
prior surgery, nevertheless the administration 
of longer-acting agents, for instance, phenoxy-
benzamine and doxazosin should be postponed 
12-24 hours before surgery. 
The most common induction agents of choice are 
etomidate and propofol. The airway instrumenta-
tion procedure should be done only after the patient 
have been reached an appropriate depth of anesthe-
sia to prevent sudden tachycardia and hypertensive 
crisis. The use of all the drugs which may precipitate 
histamine release must be averted, and neuromus-
cular blocker agent usage just before laryngoscopy 
becomes crucial. The most favorable agent of choice 
is vecuronium it has no any either autonomic effect 
or histamine release, and it is frequently used as 
paralytic agents of PCC resection. Pressor effect 
attenuation due to direct laryngoscopy becomes the 
main aspect over anesthesia induction, and common 
additional drugs should be given include a small 
dose of fentanyl, intravenous lidocaine, esmolol 
0.5 mg/kg bolus and continued infusion as indicated, 
along with nitroglycerin, nicardipine, and sodium 
nitroprusside as indicated. Inhalation agents, for 
instance, enflurane and sevoflurane are routinely 
used in the past as a result of their less-fluctuating 
hemodynamic profile and non  - arrhythmogenic 
effect. Nitrous oxide can also be used.5
The opiate use varies on the approach, patient 
tolerance, and hemodynamic issues. Long-acting 
opiates agents, for example, morphine and hydro-
morphone are widely used, although several 
later studies have successfully reported the use 
of remifentanil as well. In the past few years, 
spinal and epidural regional technique anesthesia 
have been preferably used with satisfying results. 
Nevertheless, the caution should be warranted 
regarding hemodynamic response.1 Hypertension 
might be provoked by several surgery stimulations 
for instance positioning, incision, and intubation 
procedure; however, it tends to be temporary and 
responds rapidly to the therapy.
On the other hand, tumor manipulation may 
precipitate much more dramatic effects in response 
to an increase of epinephrine and norepinephrine 
level in plasma. The hemodynamic crisis is typically 
mediated by epinephrine or norepinephrine (it 
depends on the predominant type of catecholamine 
released by a tumor) and manifested as extreme 
bradycardia followed by hypertension or severe 
tachycardia and tachyarrhythmia. The prompt 
management includes deepening the depth of anes-
thesia and immediate arterial vasodilator admin-
istration, which sodium nitroprusside becomes 
mainstay therapy about nitroglycerin to reduce 
preload. These both medications have a rapid 
onset of action and easily titrated. In refractory 
cases, nicardipine and fenoldopam have been used 
successfully. The furthest dopamine (DA-1) agonist 
causes peripheral vasodilatation with increasing 
renal blood flow concomitantly. Magnesium sulfate 
has also been used widely for hemodynamic control 
regarding its strong vasodilator effect which acts as 
direct catecholamine receptor inhibition in PCC 
resection. It also exhibits a strong calcium antago-
nist effect. The comprehensive communication with 
the surgeon is a crucial aspect prior manipulation 
of that tumor in diminishing sudden hemodynamic 
instability. Since hyperglycemic fluctuation often 
occurs due to an excessive catecholamine amount 
and insulin infusion therapy, hence it also has to be 
routinely managed. 
The abrupt changes of hypotension might be 
caused by tumor ligation in relation with contracted 
plasma volume, surgical bleeding, and anesthe-
sia-induced vasodilation which provoke profound 
and refractory hypotension. To a certain extent, 
an essential communication with the surgeon will 
possible to restore this deteriorating state by admin-
istering a large volume of bolus infusion just before 
that ligation procedure. The use of a vasoactive 
agent, DA-1, norepinephrine, and vasopressin are 
also beneficial, especially in a refractory circulatory 
shock which the acute vasopressin therapy has been 
increasingly preferred. It is due to the nondependent 
effect of vasopressin to the peripheral adrenergic 
receptor for its pressor effect after tumor resection. 
Several recent findings have documented the use of 
IV methylene blue, particularly for hemodynamic 
rescue after resection. It may act through a cyclic 
guanosine monophosphate inhibition mechanism 
which responsible in vasoplegic syndromes. The 
steroid administration might also be considered for 
a patient undergoing bilateral adrenalectomies with 
persistent hypotensive.6
Postoperative care has to be delivered in the 
intensive care unit, and invasive blood pressure 
monitoring should be conducted in the first 
24 hours. Postoperative hypertension might be 
provoked by unbearable pain, previous history of 
essential hypertension, urinary retention, and fluid 
overload. Furthermore, incomplete tumor removal 
or even metastatic process may cause postoperative 
persistent hypertension. Long term steroid therapy 
is indicated for a patient who underwent bilateral 
adrenalectomies surgery. Appropriate monitoring 
of blood glucose is also important as the postop-
erative rebound hypoglycemia may occur in rela-
tion with no longer existence of norepinephrine 
inhibitory effect towards insulin-secreting cells; 
furthermore, this symptom might also be masked 
by β-blocker administration.7 
128 Published by DiscoverSys | Bali Journal of Anesthesiology 2019; 3(2): 125-128 | doi: 10.15562/bjoa.v3i2.155
ORIGINAL ARTICLE
CONCLUSION
PCC tumor represents significant challenges for 
anesthetist with regards to optimizing its periopera-
tive management approach and reducing morbidity 
and mortality rate which are related to its resection 
procedure. The meticulous understanding of its 
pathophysiology and pharmacological agents used 
before surgery, along with intensive hemodynamic 
monitoring will eventually determine the success-
ful outcome of the surgical intervention. 
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